Webinars from the Arcinova team
About this Event
A client sought approval for a volatile pain killing compound to be used in emergency situations. It was crucial for the client to acquire a fluoride assay to prove the drug did not cause fluoride toxicity to the kidney. The team were able to develop the assay which supported an entire clinical trial using this method. The drug is now on the market, helping to save lives.
Michael Blackburn, Method Development Team Leader, discusses the effect of Fluorine exposure on the liver and the measurement of Fluoride in plasma by GCMS. Michael presents his findings, alongside the bioanalytical challenges faced and lessons learnt.
Please click the image below to view the webinar